119 related articles for article (PubMed ID: 32664845)
1. The Tumor Suppressor Role of the Ras Association Domain Family 10.
Hou Y; Li S; Du W; Li H; Wen R
Anticancer Agents Med Chem; 2020; 20(18):2207-2215. PubMed ID: 32664845
[TBL] [Abstract][Full Text] [Related]
2. RASSF10 is epigenetically silenced and functions as a tumor suppressor in gastric cancer.
Wei Z; Chen X; Chen J; Wang W; Xu X; Cai Q
Biochem Biophys Res Commun; 2013 Mar; 432(4):632-7. PubMed ID: 23428420
[TBL] [Abstract][Full Text] [Related]
3. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
Li X; Liang Q; Liu W; Zhang N; Xu L; Zhang X; Zhang J; Sung JJ; Yu J
Oncogene; 2016 May; 35(19):2453-64. PubMed ID: 26279301
[TBL] [Abstract][Full Text] [Related]
4. RASSF10 suppresses colorectal cancer growth by activating P53 signaling and sensitizes colorectal cancer cell to docetaxel.
Guo J; Yang Y; Yang Y; Linghu E; Zhan Q; Brock MV; Herman JG; Zhang B; Guo M
Oncotarget; 2015 Feb; 6(6):4202-13. PubMed ID: 25638156
[TBL] [Abstract][Full Text] [Related]
5. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
[TBL] [Abstract][Full Text] [Related]
6. RASSF10 is epigenetically inactivated and induces apoptosis in lung cancer cell lines.
Wang Y; Ma T; Bi J; Song B; Zhou Y; Zhang C; Gao M
Biomed Pharmacother; 2014 Apr; 68(3):321-6. PubMed ID: 24433832
[TBL] [Abstract][Full Text] [Related]
7. Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer.
Dong T; Zhang M; Dong Y; Herman JG; van Engeland M; Zhong G; Guo M
Discov Med; 2015 Nov; 20(111):261-71. PubMed ID: 26645898
[TBL] [Abstract][Full Text] [Related]
8. RASSF10 is an epigenetically silenced tumor suppressor in gastric cancer.
Li Z; Chang X; Dai D; Deng P; Sun Q
Oncol Rep; 2014 Apr; 31(4):1661-8. PubMed ID: 24573726
[TBL] [Abstract][Full Text] [Related]
9. Frequent epigenetic inactivation of RASSF10 in thyroid cancer.
Schagdarsurengin U; Richter AM; Wöhler C; Dammann RH
Epigenetics; 2009 Nov; 4(8):571-6. PubMed ID: 19934646
[TBL] [Abstract][Full Text] [Related]
10. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer.
Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS
Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573
[TBL] [Abstract][Full Text] [Related]
11. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
Fan C; Wang W; Jin J; Yu Z; Xin X
Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer.
Richter AM; Walesch SK; Dammann RH
Cancers (Basel); 2016 Feb; 8(3):. PubMed ID: 26927176
[TBL] [Abstract][Full Text] [Related]
13. RASSF10 suppresses lung cancer proliferation and invasion by decreasing the level of phosphorylated LRP6.
Han X; Dong Q; Wu J; Luo Y; Rong X; Han Q; Zheng X; Wang E
Mol Carcinog; 2019 Jul; 58(7):1168-1180. PubMed ID: 30834575
[TBL] [Abstract][Full Text] [Related]
14. RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker.
Jin Y; Cao B; Zhang M; Zhan Q; Herman JG; Yu M; Guo M
Genes Cancer; 2015 May; 6(5-6):231-40. PubMed ID: 26124922
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for RASSF10/NPM/RNF2 feedback cascade-mediated regulation of gastric cancer cell proliferation.
Lakshmi Ch NP; Sivagnanam A; Raja S; Mahalingam S
J Biol Chem; 2021 Aug; 297(2):100935. PubMed ID: 34224728
[TBL] [Abstract][Full Text] [Related]
16. Ras-association domain family 10 acts as a novel tumor suppressor through modulating MMP2 in hepatocarcinoma.
Liu W; Wang J; Wang L; Qian C; Qian Y; Xuan H; Zhuo W; Li X; Yu J; Si J
Oncogenesis; 2016 Jun; 5(6):e237. PubMed ID: 27348267
[TBL] [Abstract][Full Text] [Related]
17. DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia.
Younesian S; Shahkarami S; Ghaffari P; Alizadeh S; Mehrasa R; Ghavamzadeh A; Ghaffari SH
Leuk Res; 2017 Oct; 61():33-38. PubMed ID: 28869817
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer.
Richter AM; Walesch SK; Würl P; Taubert H; Dammann RH
Oncogenesis; 2012 Jun; 1(6):e18. PubMed ID: 23552700
[TBL] [Abstract][Full Text] [Related]
19. RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi.
Helmbold P; Richter AM; Walesch S; Skorokhod A; Marsch WCh; Enk A; Dammann RH
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):687-94. PubMed ID: 22113481
[TBL] [Abstract][Full Text] [Related]
20. RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice.
Richter AM; Woods ML; Küster MM; Walesch SK; Braun T; Boettger T; Dammann RH
Oncogene; 2020 Apr; 39(15):3114-3127. PubMed ID: 32047266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
